A Review Study on Operational Parameters and Biological Reactors Suitability for VOC Biodegradation in Drug and Pharmaceutical Industrial Wastewater


  • Sumitra Chakraborty


The majority of the components that make up pharmaceutical industry wastewater are solvents. During the treatment of treating this kind of industrial waste water, there is a significant risk of the emission of volatile organic compounds. The toxicity caused by solvents has a negative impact on the efficiency of anaerobic systems, while the considerable aeration that occurs during the aerobic process helps to increase the removal of volatile organic compounds into the atmosphere. The majority of the earlier experiments focused on removing COD from wastewater from pharmaceutical companies. It is necessary to have an understanding of the variables that promote the system of volatile organic compounds (VOCs) in biological systems in order to investigate the many solutions available for lowering their emission. Throughout this paper, the ways that volatile organic compounds (VOC) can be controlled from biological reactors are emphasized. This study came to the conclusion that biological systems with high biomass retention, longer hydraulic retention times, and controlled air flow speeds up the breakdown of volatile organic compounds (VOC) in wastewater. This leads to less VOC being released from wastewater treatment units, which is a good thing.

How to cite this article: Chakraborty S. A Review Study on Operational Parameters and Biological Reactors Suitability for VOC Biodegradation in Drug and Pharmaceutical Industrial Wastewater. J Durg Dis Dev 2022; 6(1): 14-18.


Chen, W.H., Yang, W.B., Yuan, C.S., Yang, J.C. and Zhao, Q.L. (2013). Influences of aeration and biological treatment on the fates of aromatic VOCs in wastewater treatment processes. Aerosol and Air Quality Research, 13: 225-236.

Dawery, S. (2013). Methanol removal from methanol-water mixture using municipal activated sludge. Journal of Engineering Science and Technology, 8(5): 578-587.

EPA (2006) Toxic Release Inventory, U.S. Environmental Protection Agency, http:// www.epa.gov/tri/tridata/tri05/index.htm. Last accessed, 10, January, 2010.

Hsi, C.W. (2009). Using a biological aerated filter to treat mixed water-borne volatile organic compounds and assessing its emissions. Journal of Environmental Sciences, 21: 1497–1502.

Hsieh, C. C. (2000). Removal mechanisms of VOCs in an activated sludge process. Journal of hazardous materials, 79(1):173-187.

Masse, A., Sperandio, M., Cabassud, C. (2006). Comparison of sludge characteristics and performance of a submerged membrane bioreactor and an activated sludge process at high solids retention time. Water Research, 40:2405-2415.

Ming, W.Y., Min, Y., Yu, Z., Chun, G.M. and Jing, Z. (2004). Biological removal of methanol from process condensate for the purpose of reclamation. Journal of Environmental Science 16(3): 384-386.

Moura, S.C., Jorge, R.F., Duque, A., Boaventura, R.A.R . and Castro, P.M.L. (2007). Aerobic biological treatment of wastewaters containing dichloromethane. Journal of Chemical Technology and Biotechnology, 82: 864–869.

Oktem, Y. A., Ince, O., Sallis, P., Donnelly, T and Ince, B. K. (2007). Anaerobic treatment of a chemical synthesis-based pharmaceutical wastewater in a hybrid upflow anaerobic sludge blanket reactor. Bioresource Technology, 99: 1089–1096.

Oz, N.A., Ince, O and Ince, B.K. (2004).Effect of wastewater composition on methanogenic activity in an anaerobic reactor. Journal of Environmental Science and Health, Part A: Toxic/Hazardous Substances and Environmental Engineering, 39 (11-12) : 2941-2953.

Ozdemir, C., Sen, N., Dursun, S. and Kalipchi, E. (2010). Removal of dichloromethane in up-flow anaerobic sludge bed reactors and methane production. Asian Journal of Chemistry, 22(8): 6423-6436.

Priya, V. S., and Philip. L., (2015a). Treatment of volatile organic compounds in pharmaceutical wastewater using submerged aerated biological filter. Chemical Engineering Journal, 266: 309-319.

Priya, V. S., and Philip. L., (2015b.). Membrane bioreactor for the treatment of voc laden pharmaceutical wastewater: Effect of biological treatment systems on membrane performance. Journal of Water Process Engineering, 7:61-73.

Quesnel, D., Nakhla, G. (2006). Removal kinetics of acetone and MIBK from a complex industrial wastewater by an acclimatized activated sludge. Journal of Hazardous Material B, 132: 253-260.

Raghuvanshi, S., Gupta, S. and Babu, B. V. (2013). Growth Kinetics of Acclimated Mixed Culture for Degradation of Isopropyl Alcohol (IPA). Journal of Biotechnology & Biomaterials.

Raj, D.S.S., and Anjaneyulu, Y. (2005). Evaluation of biokinetic parameters for pharmaceutical wastewaters using aerobic oxidation integrated with chemical treatment. Process Biochemistry, 40:165-175.

Saleem, M. (2007). Pharmaceutical wastewater treatment: a physicochemical study. Journal of Research (Science), 18(2):125-134.

Saravanane, R., Murthy, D.V.S. and Krishnaiah, K. (2001). Treatment of anti-osmotic drug based pharmaceutical effluent in an upflow anaerobic fluidized bed system. Waste Management, 22: 563-568.

Sirtori, C., Zapata, A., Oller, I., Gernjak, W., Agüera, A.and Malato, S. (2009). Decontamination industrial pharmaceutical wastewater by combining solar photo-Fenton and biological treatment. Water Research, 43(3), 661-668.

Tekin, H., Selale S.O.B., Ataberk, A. and Balta, T.H. (2006). Use of Fenton oxidation to improve the biodegradability of a pharmaceutical wastewater. Journal of Hazardous Materials B, 136; 258-265.

Wang, Z., Xiu, G., Qiao, T., Zhao, K. and Zhang, D. (2013). Coupling ozone and hollow fibers membrane bioreactor for enhanced treatment of gaseous xylene mixture. Bioresource technology, 130: 52-58.



How to Cite

Chakraborty, S. (2022). A Review Study on Operational Parameters and Biological Reactors Suitability for VOC Biodegradation in Drug and Pharmaceutical Industrial Wastewater. Journal of Drug Discovery and Development ( ISSN:2581-6861), 6(1), 14-18. Retrieved from https://medicaljournalshouse.com/index.php/JDrug-Discovery-Development/article/view/928